‘How to’ – Stability Studies

Stability study reports are a critical component of Abbreviated New Drug Application (ANDA) submissions to the US FDA, providing evidence that a generic drug product maintains the same quality, safety, and efficacy as its reference listed drug (RLD) over its shelf life. Properly developing stability study reports in compliance with FDA guidelines is essential for a successful ANDA submission. This guide provides a step-by-step approach to creating stability study reports for ANDA submissions, including practical tips, tools, and resources to ensure regulatory compliance.
Click to read the full article.

Stability testing is a vital process for establishing the shelf life and storage conditions of new dosage forms of existing drug substances. The ICH Q1C guideline provides specific instructions on conducting stability studies for new dosage forms, ensuring that they maintain their quality, safety, and efficacy over time. This guide offers a step-by-step approach to applying ICH Q1C guidelines for stability testing of new dosage forms, along with practical tips and resources to support compliance with regulatory requirements.
Click to read the full article.

After a drug product receives marketing approval, manufacturers may need to implement changes to the product or its manufacturing process, such as changes in formulation, packaging, or manufacturing site. The US FDA requires that these post-approval changes are supported by appropriate stability data to ensure that the product continues to meet its quality, safety, and efficacy standards. This guide provides a step-by-step approach to managing stability testing for post-approval changes in compliance with FDA guidelines, along with practical tips and resources.
Click to read the full article.

Stability studies are essential for demonstrating that drug products meet quality, safety, and efficacy standards over their intended shelf life. The Pharmaceutical and Medical Devices Agency (PMDA) in Japan has specific guidelines for conducting stability studies, which must be adhered to for products intended for the Japanese market. This guide provides a step-by-step approach to conducting stability studies in compliance with PMDA guidelines, including practical tips, tools, and resources to support successful regulatory submissions.
Click to read the full article.

Drug product stability testing is essential for ensuring that a drug maintains its intended quality, safety, and efficacy throughout its shelf life. The US FDA provides detailed guidance for industry on conducting stability testing, which includes recommendations for study design, storage conditions, testing intervals, and data evaluation. This guide offers a step-by-step approach to applying FDA guidance for industry on drug product stability testing, with practical tips, tools, and resources to ensure regulatory compliance.
Click to read the full article.

Orphan drugs, which are intended to treat rare diseases, have unique regulatory requirements, including stability testing to ensure they meet quality, safety, and efficacy standards. The US FDA provides specific guidance for the development and testing of orphan drugs, including stability testing. This guide provides a step-by-step approach to implementing stability testing for orphan drugs in compliance with US FDA guidelines, including practical tips, tools, and resources to support regulatory submissions.
Click to read the full article.

Biosimilars are biological medicines highly similar to an already approved biological reference product. Conducting stability studies for biosimilars is crucial to demonstrate that they maintain the same quality, safety, and efficacy as their reference products. The European Medicines Agency (EMA) provides specific guidelines for conducting stability studies for biosimilars. This guide offers a step-by-step approach to conducting stability studies for biosimilars in compliance with EMA guidelines, along with practical tips and resources.
Click to read the full article.

Stress testing is a critical part of stability studies designed to identify the degradation products and understand the intrinsic stability of a drug substance or product. The ICH Q1A(R2) guidelines provide specific recommendations on conducting stress testing to ensure the quality, safety, and efficacy of pharmaceuticals. This guide offers a step-by-step approach to applying ICH Q1A(R2) guidelines for stress testing, including practical tips and resources to support regulatory compliance.
Click to read the full article.

Stability studies are essential to demonstrate that a drug product will maintain its quality, safety, and efficacy throughout its shelf life. Health Canada provides specific guidelines for conducting stability studies for drug products marketed in Canada. This guide offers a step-by-step approach to ensuring stability studies comply with Health Canada guidelines, including practical tips and resources to support successful regulatory submissions.
Click to read the full article.

Active Pharmaceutical Ingredients (APIs) require comprehensive stability testing to ensure they maintain their quality, safety, and efficacy throughout their shelf life. The ICH Q7A guidelines provide specific recommendations on conducting stability studies for APIs, which are crucial for regulatory compliance and market approval. This guide provides a step-by-step approach to conducting stability testing of APIs in accordance with ICH Q7A guidelines, including practical tips and resources.
Click to read the full article.